Value Added Product Mix Shift
Expected: FY26-FY30HIGH confidence
What: product focus: AI-driven diagnostics
Impact: Targeting $197B market
Take Solutions Ltd: Stock Analysis & Fundamentals
Data from 3w agoTake Solutions Ltd (Miscellaneous) — fundamental analysis, earnings data, and key metrics. PE: 3222.0. ROE: 644.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
Take Solutions Ltd Key Facts
What's Happening
👔Promoter stake down 48.2% this quarter
Earnings Acceleration Triggers
1. Value Added Product Mix Shift
FY26-FY30HIGH
2. Interest Cost Reduction Deleveraging
Completed Q3 FY25MEDIUM
Key Risks
1. Ongoing tax litigations totaling INR 108
HIGH2. New AI-driven healthcare model faces hurdles related to data privacy (DPDP Act)
MEDIUMSector-Specific Signals
Operational Revenue₹0 Cr0%
Contingent Tax Liabilities₹108.03 Cr
Innovation Fund Corpus₹5 CrNew
Promoter Holding %5%-4800 bps
Key Numbers
Current Price
₹44
Market Cap
644 Cr
Valuation
N/AWhy Are Take Solutions Ltd's Earnings Accelerating?
Based on Q3 FY26 (web) earnings • Updated Apr 18, 2026
Interest Cost Reduction Deleveraging
Expected: Completed Q3 FY25MEDIUM confidence
What: debt status: Debt-free
Impact: Zero interest cost
What Are the Key Risks for Take Solutions Ltd?
Earnings deceleration risks from management commentary
Ongoing tax litigations totaling INR 108
HIGHTrigger: Ongoing tax litigations totaling INR 108.03 crore in contingent liabilities and unresolved tax exposures.
Impact: PAT impact: Potential loss of ₹108.03 Cr
Management view: Management is focusing on resolving pending litigations in India to stabilize the financial position.
Monitor: litigation
New AI-driven healthcare model faces hurdles related to data privacy (DPDP Act)
MEDIUMTrigger: New AI-driven healthcare model faces hurdles related to data privacy (DPDP Act) and medical device approvals.
Management view: Aligning platforms with IndiaAI Mission and Ayushman Bharat Digital Mission (ABDM) standards.
Monitor: regulatory
What Did Take Solutions Ltd Report This Quarter?
Headline numbers from the latest earnings call
Revenue
₹1.46 Cr
YoY -82.9%
Revenue from operations remained at zero, with total income driven primarily by other income sources.
EBITDA
₹1.11 Cr
YoY -80.3%Margin 76%
EBITDA was positive due to significant reduction in operating expenses as the company transitioned its core business.
PAT
₹1.11 Cr
YoY -97.7%QoQ -82.35%
Profitability was maintained despite zero operational revenue, though it fell significantly from the divestment-led gains of previous quarters.
Other Highlights
• Total expenses fell 90.4% YoY to ₹0.35 Cr due to divestment of major subsidiaries.
• Statutory auditors issued a qualified opinion regarding material uncertainty of going concern.
• Promoter holding declined to approximately 5% following significant exits in late 2025.
What Sector Metrics Matter for Take Solutions Ltd?
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Operational Revenue
₹0 Cr
YoY 0%QoQ 0%
Why: The company has not carried out any operations during the current period following the divestment of its core clinical research arms.
Contingent Tax Liabilities
₹108.03 Cr
Why: Unresolved tax exposures and ongoing litigations from prior periods.
Innovation Fund Corpus
₹5 Cr
YoY NewQoQ New
Why: Launched to invest in AI and digital health startups as part of the new strategic pivot.
Promoter Holding %
5%
YoY -4800 bps
Why: Significant divestment by promoter group entities throughout 2025, including a 5.1% exit by Esyspro Infotech.
What Is Take Solutions Ltd's Management Guidance?
Forward-looking targets from management for FY27-FY28
Revenue Outlook
Targeting revenue visibility from platform licensing and marketplace fees.
Capex Plan
₹50 million
Innovation Fund for AI, deep tech, and digital health startups.
Volume
Targeting deployment of 'One Minute Clinic' AI diagnostic units.
Management Tone: CAUTIOUS
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Other Top Miscellaneous Stocks Beating Nifty 500
Frequently Asked Questions: Take Solutions Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What were Take Solutions Ltd's latest quarterly results?
Take Solutions Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -97.7%
What is Take Solutions Ltd's current PE ratio?
Take Solutions Ltd's current PE ratio is 3222.0x.
- Current PE: 3222.0x
- Market Cap: 644 Cr
What is Take Solutions Ltd's price-to-book ratio?
Take Solutions Ltd's price-to-book ratio is 25.2x.
- Price-to-Book (P/B): 25.2x
- Book Value per Share: ₹2
- Current Price: ₹44
Is Take Solutions Ltd a fundamentally strong company?
Take Solutions Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 11.2%
Is Take Solutions Ltd debt free?
Take Solutions Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹0 Cr
What is Take Solutions Ltd's return on equity (ROE) and ROCE?
Take Solutions Ltd's return ratios over recent years
- FY2023: ROCE -14.0%
- FY2024: ROCE -22.2%
- FY2025: ROCE 11.2%
Is Take Solutions Ltd's cash flow positive?
Take Solutions Ltd's operating cash flow is negative (FY2025).
- Cash from Operations (CFO): ₹-16 Cr
- Free Cash Flow (FCF): ₹6 Cr
- CFO/PAT Ratio: -44% (weak cash conversion)
What is Take Solutions Ltd's dividend yield?
Take Solutions Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹44
Who holds Take Solutions Ltd shares — promoters, FII, DII?
Take Solutions Ltd's shareholding pattern (Mar 2026)
- Promoters: 0.0%
- FII (Foreign): 0.3%
- DII (Domestic): 0.0%
- Public: 99.7%
Is promoter holding increasing or decreasing in Take Solutions Ltd?
Take Solutions Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 0.0% (Mar 2026)
- Previous Quarter: 0.0% (Dec 2025)
- Change: 0.00% (stable)
Is Take Solutions Ltd a new momentum entry or an established outperformer?
Take Solutions Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
What are the growth catalysts for Take Solutions Ltd?
Take Solutions Ltd has 2 key growth catalysts identified from recent earnings analysis
- Value Added Product Mix Shift — The shift from legacy services to high-margin AI platforms is the central thesis for the company's survival and growth.
- Interest Cost Reduction Deleveraging — Zero debt provides a clean slate for the new AI-led business model despite the lack of current revenue.
What are the key risks in Take Solutions Ltd?
Take Solutions Ltd has 2 key risks worth monitoring
- [HIGH] Ongoing tax litigations totaling INR 108 — Ongoing tax litigations totaling INR 108.03 crore in contingent liabilities and unresolved tax exposures.
- [MEDIUM] New AI-driven healthcare model faces hurdles related to data privacy (DPDP Act) — New AI-driven healthcare model faces hurdles related to data privacy (DPDP Act) and medical device approvals.
What is Take Solutions Ltd's management guidance for growth?
Take Solutions Ltd's management has provided the following forward guidance for FY27-FY28
- Revenue outlook: Targeting revenue visibility from platform licensing and marketplace fees.
- Margin outlook: Not Given
- Capex plan: ₹50 million for Innovation Fund for AI, deep tech, and digital health startups.
- Management tone: cautious
What sector-specific metrics matter most for Take Solutions Ltd?
Take Solutions Ltd's most important sub-sector-specific KPIs from the latest concall
- Operational Revenue: ₹0 Cr (YoY 0%) (QoQ 0%) — The company has not carried out any operations during the current period following the divestment of its core clinical research arms.
- Contingent Tax Liabilities: ₹108.03 Cr — Unresolved tax exposures and ongoing litigations from prior periods.
- Innovation Fund Corpus: ₹5 Cr (YoY New) (QoQ New) — Launched to invest in AI and digital health startups as part of the new strategic pivot.
- Promoter Holding %: 5% (YoY -4800 bps) — Significant divestment by promoter group entities throughout 2025, including a 5.1% exit by Esyspro Infotech.
Is Take Solutions Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Take Solutions Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Take Solutions Ltd?
Take Solutions Ltd investment thesis summary:
Research Signals (Bull Case)
- Growth catalyst: Value Added Product Mix Shift
Risk Factors (Bear Case)
- Key risk: Ongoing tax litigations totaling INR 108
What is the future outlook for Take Solutions Ltd?
Take Solutions Ltd's forward outlook based on current data signals
- Key Catalyst: Value Added Product Mix Shift
- Key Risk: Ongoing tax litigations totaling INR 108
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.